Toggle Mobile Navigation

Cannabis Partnerships Congress Q&A: Lezli Engelking From FOCUS

Before she takes the podium at our upcoming Cannabis Partnerships Congress, I had the opportunity to sit down with FocusLezli Engelking to discuss cannabis regulations within the federal government and some of the challenges they face in the industry and strategies for overcoming them. The following are excerpts from that Q&A session:

Lezli Engelking

Q&A: LEZLI ENGELKING, PRESIDENT AND FOUNDER, FOCUS

What is the current state of cannabis within the federal government?

Cannabis was made illegal in the United States under the Marijuana Tax Act of 1937 and that status has not been changed since. This remains true despite more than half of the states having legalized cannabis for medical use.

How do the current regulations address quality and safety?

In most industries, agencies that control licensing for the manufacture and sale of a product recommend Good Manufacturing Practices (GMP) to ensure products are consistently produced according to quality standards.

President Clinton signed into law the National Technology and Transfer and Advancement Act of 1995. How has that had an effect on standards while writing regulations?

The National Technology Transfer and Advancement Act of 1995 (Public Law 104-113) requires all federal agencies use standards developed by voluntary consensus standards bodies instead of government-unique standards wherever possible.

Read the full Q&A session right here!

Get Involved!

Explore the full program for the Cannabis Partnerships Congress right here!

Looking to maximize this learning opportunity? Register as a group! Click here for more information.

If you would like to Sponsor or Exhibit at The Cannabis Partnerships Congress, please contact Dor Peled at dpeled@exlevents.com or 917-258-5159.

posted in ExL Events News

live chat software